Last reviewed · How we verify

NCT06100120

A Triple-blinded Non-inferiority Multicentre Randomized Controlled Trial Comparing Hybrid and Fully Etched Implants P1

Status unknown NA Last updated 1 December 2023
What this trial tests

NA trial testing Implant placement in Dental Implants in 128 participants. Status unknown.

Timeline
15 November 2023
Primary endpoint
1 November 2024
1 January 2025

Quick facts

Lead sponsorUniversity of Milan
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment128
Start date15 November 2023
Primary completion1 November 2024
Estimated completion1 January 2025
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Milan

Who can join

20 and older, any sex, with Dental Implants. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this randomized controlled clinical trial is to compare implant stability between hybrid implants and fully rough implants in partially edentulous patients. The main question it aims to answer is: are hybrid implants able to achieve a sufficient level of secondary stability in comparison to fully etched implants? Participants will receive dental implants and the secondary stability will be measured using resonance frequency analysis (RFA) at the 2-month post-implant placement mark. Implants that do not attain adequate secondary stability will undergo re-evaluation at monthly intervals up to 6 months. Researchers will compare the test group (hybrid implants) or the control group (fully rough implants) to see if they present a comparable secondary stability.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Implant placement

Trials testing the same drug.

Other recruiting trials for Dental Implants

Currently open trials in the same condition.

Other University of Milan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06100120.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing